Module 1 - Administrative information application form
The applicant should note whether an application for orphan designation, for the medicinal product concerned, has ever been submitted to the EMA for the condition that is the subject of the application for marketing authorisation, and if ‘yes’, the EMA procedure number (EMEA/OD/XXX/year or
Form, Information, Applications, Marketing, Administrative, Module, Authorisation, Module 1 administrative information application form, Application for marketing authorisation
Download Module 1 - Administrative information application form
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
Practical user guide for electronic Application Forms (eAF ...
esubmission.ema.europa.euPage 7 of 83 1.3. Application for a change to existing marketing authorisation leading to an extension as referred to in Annex I of Regulation (EC) no …
Applications, Marketing, Authorisation, Marketing authorisation
VOLUME 2A Procedures for marketing authorisation …
ec.europa.eumarketing authorisation in a Member State, the applicant/marketing authorisation holder must submit an application in the Member States concerned using the procedure of mutual recognition. The Member States concerned should then recognise the marketing authorisation already granted by the reference Member State and
Applications, Marketing, Authorisation, Marketing authorisation, For marketing authorisation
APPLICATION FORM FINANCIAL SUPPORT: DALRRD JOBS …
www.dalrrd.gov.zacredit application (“Related Party”), that it has the appropriate permission to disclose the stated personal information. In the event that the Client provides personal information and consent on behalf of a minor person (younger than 18 years old) or adult dependant unable to provide their own consent, the Client
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE …
www.ema.europa.euApplication for Marketing Authorisation of a Medicinal Products (Eudralex 3AQ9a) and the Note for Guidance on Inclusion of Antioxidants and Antimicrobial Preservatives in Medicinal Products (CPMP/CVMP/QWP/115/95). The latter Guideline remains a CVMP guideline and remains applicable to Veterinary products.
Applications, Marketing, Authorisation, Application for marketing authorisation of
ECO PASSPORT Application - oeko-tex.com
www.oeko-tex.comApplication: ECO PASSPORT by OEKO‑TEX® To the Institute / An das Institut Application Antrag For authorisation to use the ECO PASSPORT by OEKO‑TEX® mark for the articles designated in section 2 of this application. Für die Berechtigung zur Nutzung der Marke ECO PASSPORT by OEKO‑TEX® für die in Abschnitt 2 bezeichneten Artikel dieses An-